NCT05524428 Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
| NCT ID | NCT05524428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Colo-rectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 2 participants |
| Start Date | 2023-03-24 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2 participants in total. It began in 2023-03-24 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will use a mixed methods study i.e. focus groups involving CHC staff as well as quantitative study which involves analyzing data that is available from the EHR and DRVS population management platform.
Eligibility Criteria
Inclusion Criteria: * Staff members at partnering sites (see locations) who are administrative leaders, population health managers, data analysts, quality improvement staff, nurses, nurse managers, practice managers, medical assistants, and providers. * Staff members at partnering sites ages 18+. Exclusion Criteria: * Staff members that are not involved in CRC screening practices at CHCs.
Contact & Investigator
Adjoa Anyane-Yeboa, MD, MPH
PRINCIPAL INVESTIGATOR
Mass General Hospital // Harvard Medical School
Frequently Asked Questions
Who can join the NCT05524428 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colo-rectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05524428 currently recruiting?
Yes, NCT05524428 is actively recruiting participants. Contact the research team at aanyane-yeboa@mgh.harvard.edu for enrollment information.
Where is the NCT05524428 trial being conducted?
This trial is being conducted at Boston, United States, Brockton, United States, East Boston, United States, Hyannis, United States.
Who is sponsoring the NCT05524428 clinical trial?
NCT05524428 is sponsored by Massachusetts General Hospital. The principal investigator is Adjoa Anyane-Yeboa, MD, MPH at Mass General Hospital // Harvard Medical School. The trial plans to enroll 2 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.